奥麦罗制药 | 11.30 +0.07 +0.62% | ||
| OMER | |||
| 高 11.45 | 开 11.18 | 量 62.97万股 | 总市值 8.01亿 |
| 低 11.01 | 换 0.89% | 额 709.61万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
奥麦罗制药(OMER)
01-31 03:25
$奥麦罗制药(OMER)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-000206 Act: 34 Size: 6 KB 网页链接
奥麦罗制药(OMER)
01-15 06:35
$奥麦罗制药(OMER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-26-001280 Size: 10 KB 网页链接
奥麦罗制药(OMER)
01-14 05:35
$奥麦罗制药(OMER)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000386 Act: 33 Size: 5 KB 网页链接
奥麦罗制药(OMER)
01-13 05:35
$奥麦罗制药(OMER)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000358 Act: 33 Size: 5 KB 网页链接
奥麦罗制药(OMER)
01-08 06:25
$奥麦罗制药(OMER)$ 8-K Current report, item 2.02 Accession Number: 0001437749-26-000820 Act: 34 Size: 154 KB 网页链接
奥麦罗制药(OMER)
2025-12-29 19:15
$奥麦罗制药(OMER)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-25-038758 Act: 34 Size: 228 KB 网页链接
奥麦罗制药(OMER)
2025-12-01 21:35
$奥麦罗制药(OMER)$ 8-K Current report, items 1.02, 2.01, 8.01, and 9.01 Accession Number: 0001437749-25-036507 Act: 34 Size: 473 KB 网页链接
奥麦罗制药(OMER)
2025-11-14 20:35
$奥麦罗制药(OMER)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001552781-25-000420 Act: 33 Size: 639 KB 网页链接
奥麦罗制药(OMER)
2025-11-14 19:15
$奥麦罗制药(OMER)$ S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers Accession Number: 0001552781-25-000417 Act: 33 Size: 1 MB 网页链接
奥麦罗制药(OMER)
2025-11-14 05:15
$奥麦罗制药(OMER)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-25-034824 Act: 34 Size: 466 KB 网页链接
奥麦罗制药(OMER)
2025-11-14 05:15
$奥麦罗制药(OMER)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-25-034826 Act: 34 Size: 8 MB 网页链接
奥麦罗制药(OMER)
2025-10-31 23:15
$奥麦罗制药(OMER)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-25-000274 Act: 34 Size: 6 KB 网页链接
奥麦罗制药(OMER)
2025-10-16 07:25
$奥麦罗制药(OMER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-25-031087 Size: 9 KB 网页链接
1赞
奥麦罗制药(OMER)
2025-10-15 20:35
$奥麦罗制药(OMER)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001437749-25-030968 Act: 34 Size: 244 KB 网页链接
奥麦罗制药(OMER)
2025-08-15 04:25
$奥麦罗制药(OMER)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-25-026933 Act: 34 Size: 8 MB 网页链接
奥麦罗制药(OMER)
2025-08-15 04:15
$奥麦罗制药(OMER)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-25-026931 Act: 34 Size: 339 KB 网页链接
奥麦罗制药(OMER)
2025-07-25 20:15
$奥麦罗制药(OMER)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-25-070553 Act: 33 Size: 605 KB 网页链接
奥麦罗制药(OMER)
2025-07-25 20:15
$奥麦罗制药(OMER)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-25-070554 Act: 34 Size: 564 KB 网页链接
奥麦罗制药(OMER)
2025-07-03 04:15
$奥麦罗制药(OMER)$ 8-K Current report, item 5.07 Accession Number: 0001437749-25-021959 Act: 34 Size: 177 KB 网页链接
奥麦罗制药(OMER)
2025-07-02 05:35
$奥麦罗制药(OMER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-25-021801 Size: 5 KB 网页链接